| Code | CSB-RA618886MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to DS-1055, designed to target LRRC32 (Leucine Rich Repeat Containing 32), also known as GARP (Glycoprotein A Repetitions Predominant). LRRC32 is a transmembrane protein that serves as a docking receptor for latent TGF-β on the surface of regulatory T cells (Tregs), activated platelets, and certain cancer cells. By anchoring latent TGF-β to the cell surface, LRRC32 facilitates the localized activation of this immunosuppressive cytokine, playing a critical role in immune homeostasis and tolerance. Dysregulated LRRC32 expression has been implicated in various pathological conditions, including cancer immune evasion, fibrotic diseases, and autoimmune disorders, where aberrant TGF-β signaling contributes to disease progression.
DS-1055 is a reference antibody that has been investigated for its ability to block LRRC32-mediated TGF-β activation, particularly in the context of tumor immunology and Treg function. This biosimilar antibody serves as a valuable research tool for investigating LRRC32 biology, TGF-β signaling pathways, and the role of regulatory immune mechanisms in disease models.
There are currently no reviews for this product.